Medroxyprogesterone Therapy for Sexual Precocity in Girls

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

An evaluation of 13 girls who had been treated intramuscularly with medroxyprogesterone acetate for sexual precocity showed that this drug has no effect on growth, skeletal maturation, or adult height. During treatment (mean duration, 3.6 years), menstruation was suppressed and breast size initially regressed, but breast development and pubic hair development progressed during long-term therapy. The extent of delay in resumption of menses after cessation of therapy was related both to duration of treatment and dosage of the drug.

Original languageEnglish (US)
Pages (from-to)443-445
Number of pages3
JournalAmerican Journal of Diseases of Children
Volume135
Issue number5
DOIs
StatePublished - May 1981

Fingerprint

Medroxyprogesterone
Menstruation
Breast
Medroxyprogesterone Acetate
Therapeutics
Pharmaceutical Preparations
Hair
Sexual precocity
Growth

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{4816d5a10bef40f886de0741968300ee,
title = "Medroxyprogesterone Therapy for Sexual Precocity in Girls",
abstract = "An evaluation of 13 girls who had been treated intramuscularly with medroxyprogesterone acetate for sexual precocity showed that this drug has no effect on growth, skeletal maturation, or adult height. During treatment (mean duration, 3.6 years), menstruation was suppressed and breast size initially regressed, but breast development and pubic hair development progressed during long-term therapy. The extent of delay in resumption of menses after cessation of therapy was related both to duration of treatment and dosage of the drug.",
author = "Lee, {Peter A.}",
year = "1981",
month = "5",
doi = "10.1001/archpedi.1981.02130290041015",
language = "English (US)",
volume = "135",
pages = "443--445",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "5",

}

Medroxyprogesterone Therapy for Sexual Precocity in Girls. / Lee, Peter A.

In: American Journal of Diseases of Children, Vol. 135, No. 5, 05.1981, p. 443-445.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Medroxyprogesterone Therapy for Sexual Precocity in Girls

AU - Lee, Peter A.

PY - 1981/5

Y1 - 1981/5

N2 - An evaluation of 13 girls who had been treated intramuscularly with medroxyprogesterone acetate for sexual precocity showed that this drug has no effect on growth, skeletal maturation, or adult height. During treatment (mean duration, 3.6 years), menstruation was suppressed and breast size initially regressed, but breast development and pubic hair development progressed during long-term therapy. The extent of delay in resumption of menses after cessation of therapy was related both to duration of treatment and dosage of the drug.

AB - An evaluation of 13 girls who had been treated intramuscularly with medroxyprogesterone acetate for sexual precocity showed that this drug has no effect on growth, skeletal maturation, or adult height. During treatment (mean duration, 3.6 years), menstruation was suppressed and breast size initially regressed, but breast development and pubic hair development progressed during long-term therapy. The extent of delay in resumption of menses after cessation of therapy was related both to duration of treatment and dosage of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0019475160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019475160&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1981.02130290041015

DO - 10.1001/archpedi.1981.02130290041015

M3 - Article

C2 - 7234772

AN - SCOPUS:0019475160

VL - 135

SP - 443

EP - 445

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 5

ER -